These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7423967

  • 21. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.
    Karazindiyanoğlu S, Cayan S.
    Aging Male; 2008 Sep; 11(3):146-9. PubMed ID: 18821291
    [Abstract] [Full Text] [Related]

  • 22. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC, Kirby RS.
    Prostate Cancer Prostatic Dis; 2006 Sep; 9(1):14-8. PubMed ID: 16264770
    [Abstract] [Full Text] [Related]

  • 23. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
    Seftel A.
    Int J Impot Res; 2007 Sep; 19(1):2-24. PubMed ID: 16193074
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I, Lubina A, Gorfine M, Ilany J.
    J Androl; 2006 Sep; 27(3):358-64. PubMed ID: 16474013
    [Abstract] [Full Text] [Related]

  • 26. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ, Cueva Martínez A, Martin Braun P, Fernández Arancibia MI, Jünemann KP, Alken P.
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [Abstract] [Full Text] [Related]

  • 27. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V, Zirilli L, Madeo B, Aranda C, Caffagni G, Fabre B, Montangero VE, Roldan EJ, Maffei L, Carani C.
    Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
    [Abstract] [Full Text] [Related]

  • 28. Testosterone release rate and duration of action of testosterone pellet implants.
    Kelleher S, Howe C, Conway AJ, Handelsman DJ.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):420-8. PubMed ID: 15049955
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cardiovascular issues in hypogonadism and testosterone therapy.
    Shabsigh R, Katz M, Yan G, Makhsida N.
    Am J Cardiol; 2005 Dec 26; 96(12B):67M-72M. PubMed ID: 16387571
    [Abstract] [Full Text] [Related]

  • 32. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M, Lipshultz LI.
    Urol Clin North Am; 2007 Nov 26; 34(4):549-53, vi. PubMed ID: 17983894
    [Abstract] [Full Text] [Related]

  • 33. Testosterone replacement therapy for older men.
    Wald M, Meacham RB, Ross LS, Niederberger CS.
    J Androl; 2006 Nov 26; 27(2):126-32. PubMed ID: 16474018
    [No Abstract] [Full Text] [Related]

  • 34. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM, Heinemann L, Morales A, Pexman-Fieth C.
    Aging Male; 2008 Jun 26; 11(2):101-6. PubMed ID: 18570063
    [Abstract] [Full Text] [Related]

  • 35. Treatment of hypogonadism in men with chronic kidney disease.
    Johansen KL.
    Adv Chronic Kidney Dis; 2004 Oct 26; 11(4):348-56. PubMed ID: 15492971
    [Abstract] [Full Text] [Related]

  • 36. The aging male--diagnosis and therapy of late-onset hypogonadism.
    Schreiber G, Ziemer M.
    J Dtsch Dermatol Ges; 2008 Apr 26; 6(4):273-9. PubMed ID: 18218041
    [Abstract] [Full Text] [Related]

  • 37. [Hormone replacement Up-to-date. LOH and testosterone replacement therapy: clinical application].
    Yasuda M.
    Clin Calcium; 2007 Sep 26; 17(9):1326-33. PubMed ID: 17767020
    [Abstract] [Full Text] [Related]

  • 38. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ.
    J Androl; 1998 Sep 26; 19(6):761-8. PubMed ID: 9876028
    [Abstract] [Full Text] [Related]

  • 39. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
    Ebert T, Jockenhövel F, Morales A, Shabsigh R.
    Eur Urol; 2005 Feb 26; 47(2):137-46. PubMed ID: 15661407
    [Abstract] [Full Text] [Related]

  • 40. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M, Canty DJ, Shabsigh R.
    Postgrad Med; 2008 Sep 26; 120(3):130-53. PubMed ID: 18824832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.